University of Wisconsin–Madison researchers have developed a promising technique for treating osteoarthritis using therapeutic blood clots activated by messenger RNA.

Scientists in the US say they have developed an mRNA-based vaccine that encompasses ... way to go from the animal model to humans. The type of response, the extent of the response, the persistence ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Moderna (MRNA) closed the latest trading day at $41. ... To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional ...

Lastly, vaccine hesitancy could plague vaccine-focused firms like Moderna if new concerns about safety issues begin to emerge from the firm's novel mRNA vaccines. We model this into our demand ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

In that respect it follows a similar model to Merck's takeover of AmpTec, another CDMO that uses a PCR platform to make mRNA drugs, for an undisclosed sum last year. Outsourcing services are on of ...

Moderna (MRNA) closed at $34.45 in the latest trading ... changes into account and delivers a clear, actionable rating model. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong ...

By constructing a mouse model with a complete knockout of the Martre ... and third-generation sequencing to measure mRNA poly(A) tail lengths, the researchers demonstrated that MARTRE proteins ...

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...